Warren Eric
Esperion Therapeutics, Inc. · Chief Commercial Officer
Warren Eric is listed in filings as Chief Commercial Officer at Esperion Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 21, 2025, including sale activity. Recent filings connect the profile to Esperion Therapeutics, Inc. (ESPR). The current snapshot covers public activity from Jun 20, 2024 to Apr 21, 2025. Reported amounts are shown as $106 to $286.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $106108 shares | SellApr 17, 2025 | $0.978 | $3.13 |